Cisplatin v cetuximab for HPV associated oropharyngeal cancer
22 Oct 2018
Cisplatin v cetuximab for HPV associated oropharyngeal cancer
ESMO 2018: Melanoma highlights
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma
ESMO 2018: Highlights
Detecting copy number alterations using a pre-natal test
PEACE: Collecting cancer tissue to solve the riddle of metastasis
The past, present and future of treating ovarian cancer
Comment on new treatment options for breast cancer
Economics and education around biosimilars
Societal indicators of lung cancer screening behaviours
In vitro diagnostic models for ALL: what can we learn on actionable targets?
Latest concepts in the diagnosis of genetic ALL subtypes